By contrast, Vioxx made $2.5 billion for Merck last year.
Celebrex and Vioxx have become household names in recent years.
Vioxx was easier on the stomach than aspirin, but it cost more.
Merck's decision to withdraw Vioxx cast suspicion on the safety of drugs in that class.
Vioxx was Merck's fourth top seller, and they knew their decision would be extremely harmful to the company.
The company was already facing two class action lawsuits alleging patient harm from Vioxx.
``This morning Merck is announcing a voluntary worldwide withdrawal of Vioxx,'' Gilmartin began.
The FDA's own study of the Vioxx safety issue has become mired in controversy.
